Verition Fund Management LLC decreased its position in HCA Healthcare Inc (NYSE:HCA) by 62.2% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,994 shares of the company’s stock after selling 9,880 shares during the quarter. Verition Fund Management LLC’s holdings in HCA Healthcare were worth $615,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in the business. WINTON GROUP Ltd increased its position in shares of HCA Healthcare by 39.6% during the first quarter. WINTON GROUP Ltd now owns 6,954 shares of the company’s stock valued at $675,000 after buying an additional 1,973 shares during the period. Knightsbridge Asset Management LLC purchased a new position in shares of HCA Healthcare during the first quarter valued at about $10,711,000. Summit Trail Advisors LLC increased its position in shares of HCA Healthcare by 9,933.3% during the first quarter. Summit Trail Advisors LLC now owns 112,774 shares of the company’s stock valued at $113,000 after buying an additional 111,650 shares during the period. Howard Capital Management Inc. increased its position in shares of HCA Healthcare by 25.7% during the first quarter. Howard Capital Management Inc. now owns 3,282 shares of the company’s stock valued at $319,000 after buying an additional 670 shares during the period. Finally, Suntrust Banks Inc. increased its position in shares of HCA Healthcare by 365.6% during the first quarter. Suntrust Banks Inc. now owns 23,513 shares of the company’s stock valued at $2,279,000 after buying an additional 18,463 shares during the period. Hedge funds and other institutional investors own 70.37% of the company’s stock.

HCA has been the topic of several research analyst reports. SunTrust Banks boosted their price target on shares of HCA Healthcare to $150.00 and gave the company a “positive” rating in a research report on Tuesday, September 4th. Jefferies Financial Group boosted their price target on shares of HCA Healthcare to $155.00 and gave the company a “buy” rating in a research report on Friday, September 21st. Cantor Fitzgerald reiterated a “buy” rating and set a $115.00 price target on shares of HCA Healthcare in a research report on Friday, July 20th. Zacks Investment Research upgraded shares of HCA Healthcare from a “hold” rating to a “buy” rating and set a $119.00 price target on the stock in a research report on Monday, July 16th. Finally, Morgan Stanley boosted their price target on shares of HCA Healthcare from $91.00 to $98.00 and gave the company an “underweight” rating in a research report on Friday, July 13th. Two analysts have rated the stock with a sell rating, six have assigned a hold rating and eighteen have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $131.62.

In other news, insider Jonathan B. Perlin sold 83,298 shares of the company’s stock in a transaction that occurred on Friday, July 27th. The shares were sold at an average price of $122.00, for a total value of $10,162,356.00. Following the transaction, the insider now owns 105,394 shares in the company, valued at $12,858,068. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP Kathryn A. Torres sold 1,689 shares of the company’s stock in a transaction that occurred on Wednesday, July 25th. The stock was sold at an average price of $112.53, for a total transaction of $190,063.17. Following the completion of the transaction, the senior vice president now owns 10,057 shares in the company, valued at approximately $1,131,714.21. The disclosure for this sale can be found here. Insiders have sold 170,257 shares of company stock worth $21,118,053 in the last three months. 2.80% of the stock is currently owned by insiders.

NYSE:HCA opened at $136.63 on Thursday. HCA Healthcare Inc has a one year low of $71.18 and a one year high of $138.18. The company has a debt-to-equity ratio of -7.64, a quick ratio of 1.15 and a current ratio of 1.36. The stock has a market cap of $46.55 billion, a P/E ratio of 16.92, a price-to-earnings-growth ratio of 1.19 and a beta of 0.54.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Wednesday, July 25th. The company reported $2.29 EPS for the quarter, topping the consensus estimate of $2.16 by $0.13. HCA Healthcare had a net margin of 6.21% and a negative return on equity of 61.68%. The business had revenue of $11.53 billion for the quarter, compared to analyst estimates of $11.32 billion. During the same quarter in the previous year, the firm posted $1.73 earnings per share. HCA Healthcare’s quarterly revenue was up 7.4% on a year-over-year basis. research analysts anticipate that HCA Healthcare Inc will post 9.23 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 28th. Investors of record on Tuesday, September 4th will be paid a dividend of $0.35 per share. This represents a $1.40 annualized dividend and a yield of 1.02%. The ex-dividend date of this dividend is Friday, August 31st. HCA Healthcare’s payout ratio is currently 21.24%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Further Reading: What does the Dow Jones Industrial Average (DJIA) measure?

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.